Stock Earnings

Question 1

What are Silexion Therapeutics Corp's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Silexion Therapeutics Corp has a total asset of $2, Net loss of $-16

Question 2

What are the key financial ratios for SLXN?

Accepted Answer

Silexion Therapeutics Corp's Current ratio is 0.33, has a Net margin is 0, sales per share of $0.

Question 3

How is Silexion Therapeutics Corp's revenue broken down by segment or geography?

Accepted Answer

Currently Silexion Therapeutics Corp data is not available.

Question 4

Is Silexion Therapeutics Corp profitable?

Accepted Answer

no, according to the latest financial statements, Silexion Therapeutics Corp has a net loss of $-16

Question 5

Does Silexion Therapeutics Corp have any liabilities?

Accepted Answer

yes, Silexion Therapeutics Corp has liability of 6

Question 6

How many outstanding shares for Silexion Therapeutics Corp?

Accepted Answer

Silexion Therapeutics Corp has a total outstanding shares of 0.12

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	4	6	0	1	0	--
Research & Development	4	5	3	--	--	--
Operating Expenses	9	12	6	1	0	0
Other Non Operating Income (Expenses)	0	0	0	--	--	--
Pretax Income	-9	-16	-5	0	0	0
Income Tax Expense	0	0	0	--	--	--
Net Income	-9	-16	-5	0	0	0
Net Income Growth	-25%	220%	--	--	--	--
Shares Outstanding (Diluted)	1.13	0.12	0.07	0.07	13.18	14.86
Shares Change (YoY)	1,268%	70%	0%	-99%	-11%	--
EPS (Diluted)	-8.16	-134.03	-70.58	8.01	-0.06	-0.01
EPS Growth	-95%	90%	-981%	-13,450%	500%	--
Free Cash Flow	-10	-8	-4	0	-1	0
Free Cash Flow Per Share	-8.82	-64.88	-55.24	0	-0.07	0
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-9	-12	-6	--	--	--
EBITDA Margin	0%	0%	0%	--	--	--
D&A For EBITDA	0	0	0	--	--	--
EBIT	-9	-12	-6	-1	0	0
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	--	--	--

Silexion Therapeutics Corp (SLXN) Price